Pharmaceuticals & Therapeutics

Pharma manufacturer Mikart cuts the ribbon on a new Atlanta HQ while boosting bottling capacity by 50%, tackling industry demand and fueling local growth.

A new therapy programs immune cells inside the body to fight disease. Sail Biomedicines is pioneering this approach to offer a potential cure for autoimmunity.

A Leominster senior community earned top national honors from U.S. News & World Report. Discover what this data-driven award reveals about quality of care.

A Shelton community earns top national honors from U.S. News & World Report, a distinction driven entirely by outstanding resident and family feedback.

New Phase 2a data reveals Oruka Therapeutics' ORKA-001 achieved complete skin clearance in nearly two-thirds of patients, positioning it as a potential game-changer.

Alliance Cancer Specialists and IDEOlogy Health unite to bring the latest cancer research directly to community care teams, enhancing patient outcomes.

A new report reveals payers are rewriting drug benefit rules, sacrificing rebates for more control as they grapple with the high cost of new therapies.

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

WACKER is set to reveal a cost-saving XRF testing method and a breakthrough gamma-sterilizable medical adhesive, poised to impact two key sectors.

Milwaukee's Zurn Elkay named a top US Climate Leader again, proving that deep cuts in emissions can fuel business success and solve real-world water issues.

In a key human trial, Sona Nanotech's heat-based therapy saw a 60% complete response in tumors for melanoma patients who had exhausted other options.

With 65% of its medical tourism revenue from Indonesia, Malaysia is doubling down on its most vital market through strategic outreach and world-class care.

A new competition connects emerging shelf-stable brands with 200+ retail buyers, offering a direct path to national shelf space in a crowded market.

A landmark $41M donation from the Weston family to Sunnybrook aims to overhaul Canada's clinical trial landscape, promising faster patient access to therapies.

Citius Pharmaceuticals raises crucial capital for its new cancer drug, but the deal's structure prompts a classic biotech debate: growth vs. shareholder value.

Millions are using GLP-1 drugs for weight loss, but an unexpected side effect is emerging: a prominent 'buffalo hump' that surgery is now targeting.

A new partnership brings a psychology-based diabetes reversal program to millions, offering a corporate-funded alternative to popular GLP-1 medications.

In a landmark decision, the DEA has rescheduled medical cannabis, unlocking scientific research, slashing industry taxes, and reshaping patient access.

As GLP-1 costs cripple employer health plans, Noom Health's new program bypasses industry middlemen, projecting massive savings and better patient outcomes.

U.S. Anesthesia Partners will settle a major antitrust lawsuit, signaling a victory for federal regulators and new rules for healthcare consolidation.